A company’s regulatory strategy can determine its success—or failure. For investors, venture capital professionals, and family office managers, understanding the key regulatory milestones in the life sciences sector is essential to assessing risk, managing timelines, and making informed investment decisions.

This virtual session will provide a deep dive into the FDA regulatory process for medical devices and life science innovations, helping you identify red flags, evaluate a company’s regulatory preparedness, and ask the right questions before investing.

What You’ll Gain:
A structured overview of regulatory pathways for medical devices, diagnostics, and combination products.
Insights into how regulatory readiness impacts valuation, funding strategies, and market entry.
Key risk factors that can delay approval and increase costs.
Practical guidance on evaluating regulatory due diligence and company readiness.

Who Should Attend:
This session is designed for investors, venture capital professionals, entrepreneurs, and family office managers seeking to strengthen their understanding of the regulatory landscape in life sciences.